Expert Information
Tips, insights, and expert information to help you manage brain and eye disease.
Our tools will help you understand and manage symptoms, treatment, and prevention of these diseases.
Gayatri S. Reilly, MD, an ophthalmologist with The Retina Group of Washington, enjoys helping people understand their eye health. She’s also an optimist when it comes to looking at the big picture of improved macular degeneration research and treatment over the last 15 years.
Mario Cornacchione, DO, recently joined BrightFocus Foundation, the parent organization for Alzheimer’s Disease Research, in a Scranton PA community forum on Alzheimer’s and caregiving. Dr. Cornacchione is a practicing physician and is also working with several clinical trials. What follows is a brief question and answer session between BrightFocus and Dr. Cornacchione.
Learn about a clinical trial that may slow the progression of advanced dry age-related macular degeneration.
Learn helpful steps that caregivers can take to protect their loved ones from wandering.
Up until now, the best method scientists have had to fight Alzheimer’s has been using drugs to treat the symptoms of the disease after they start to show. But new research offers them new hopes for treatments to attack the disease sooner.
BrightFocus is proud to have been a direct sponsor on two of three new glaucoma research studies.
In what is being hailed a “game changer” for Alzheimer’s research, researchers Rudolph E. Tanzi, PhD, and Se Hoon Choi, PhD, both BrightFocus grantees, have done the impossible. Together with their colleagues, they have managed to grow human brain cells in a laboratory for use in Alzheimer’s testing.
There are many health professionals trained to take care of your eyes. This article provides a brief description of three major types you may find in your community.
Marijuana, or Cannabis sativa, has been known to lower intraocular pressure (IOP) since the 1970s. The active component of marijuana, Δ9-tetrahydrocannabinol (THC), has been shown to lower IOP in animals and humans and in various formulations, including inhaled, oral, intravenous, sublingual, and topical. This article will address the reasons why marijuana is not recommended for the treatment of glaucoma.
